Influenza A viruses are significant human pathogens causing yearly epidemics and occasional pandemics. Past pandemics have resulted in significant morbidity and mortality. The 1918 influenza pandemic was thought to have resulted in the death of at least 675,000 people in the U.S., and 40 million people worldwide. Pandemics in 1957 and 1968, while less severe, were also of major public health importance. In 2009, a novel pandemic emerged and caused up to 18,000 deaths in the U.S. and up to 575,000 deaths globally. Understanding the molecular basis for the formation of pandemic influenza strains is critical. The 1957 and 1968 pandemics were human-avian reassortant viruses in which two or three influenza gene segments from the then circulating human influenza viruses were replaced with genes from an avian source. The 2009 pandemic virus arose via reassortment between two swine-adapted influenza viruses. Sequence and phylogenetic analysis of the 1918 pandemic virus suggested that it was derived from an avian-like virus possibly via an intermediate host in the decade before the pandemic. The 1918 pandemic virus caused several epidemiologically distinct waves. The so-called first wave, in the summer months of 1918, may have represented an early form of the more virulent second wave. To understand how this pandemic virus emerged and to model its virulence, it is important to place this virus in the context of human influenza viruses circulating before 1918 and to follow the early evolution of human H1N1 viruses after 1918. Because human influenza isolates are not available earlier than 1933, the only way to characterize these viruses is by identification of influenza RNA fragments preserved in formalin-fixed, paraffin-embedded autopsy tissues. Efforts to identify pre-1918 influenza virus RNA-positive autopsy material are continuing. Possible fatal influenza pneumonia cases from 1907-1917 have been identified in tissue archives and anonymized materials are being screened for host and viral RNA by RT-PCR. A second effort underway has been to characterize the noncoding regions of the 1918 pandemic influenza virus to complete the viral genome using a novel RACE (rapid amplification of cDNA ends)-based approach. Finally, a method has been developed allowing high-throughput deep sequencing of host, viral, and bacterial RNA from a 1918 autopsy tissue sample. This method significantly reduces ribosomal RNA allowing sequence analysis of viral and host mRNA expression and identification of secondary bacterial infections.

Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Zip Code
Wang, Ruixue; Taubenberger, Jeffery K (2014) Characterization of the noncoding regions of the 1918 influenza A H1N1 virus. J Virol 88:1815-8
Viboud, Cecile; Eisenstein, Jana; Reid, Ann H et al. (2014) Reply to Wilson et Al. J Infect Dis 210:995-7
Wang, Ruixue; Xiao, Yongli; Taubenberger, Jeffery K (2014) Rapid sequencing of influenza A virus vRNA, cRNA and mRNA non-coding regions. J Virol Methods 195:26-33
Morens, David M; Taubenberger, Jeffery K (2014) A possible outbreak of swine influenza, 1892. Lancet Infect Dis 14:169-72
Viboud, Cecile; Eisenstein, Jana; Reid, Ann H et al. (2013) Age- and sex-specific mortality associated with the 1918-1919 influenza pandemic in Kentucky. J Infect Dis 207:721-9
Xiao, Yong-Li; Kash, John C; Beres, Stephen B et al. (2013) High-throughput RNA sequencing of a formalin-fixed, paraffin-embedded autopsy lung tissue sample from the 1918 influenza pandemic. J Pathol 229:535-45
Taubenberger, J K; Morens, D M (2009) Pandemic influenza--including a risk assessment of H5N1. Rev Sci Tech 28:187-202
Morens, David M; Taubenberger, Jeffery K; Fauci, Anthony S (2009) Reply to kilbourne. J Infect Dis 199:913-4
Morens, David M; Taubenberger, Jeffery K; Fauci, Anthony S (2009) The persistent legacy of the 1918 influenza virus. N Engl J Med 361:225-9
Morens, David M; Taubenberger, Jeffery K; Folkers, Gregory K et al. (2009) An historical antecedent of modern guidelines for community pandemic influenza mitigation. Public Health Rep 124:22-5

Showing the most recent 10 out of 15 publications